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To establish the prevalence and to characterize the types 
of cardiac involvement in Friedreich's ataxia, 75 con· 
secutive patients (39 male and 36 female), aged 10 to 66 
years (mean 24) were prospectively studied. Electrocar· 
diograms were performed in all patients, vectorcardio· 
grams in 34 and echocardiograms in 58. Electrocardio· 
graphic and vectorcardiographic abnormalities oc· 
curred in 69 (92%) of the 75 patients. Electrocardio· 
grams revealed ST·T wave abnormalities in 79%, right 
axis deviation in 40%, short PR interval in 24%, abo 
normal R wave in lead V I in 20%, abnormal inferolateral 
Q waves in 14% and left ventricular hypertrophy (volt· 
age and repolarization criteria) in 16%. Echocardio· 
grams revealed concentric left ventricular hypertrophy 
in 11 %, asymmetric septal hypertrophy in 9% and glob· 
ally decreased left ventricular function in 7 %. Progreso 
sion from a normal echocardiogram to concentric left 
ventricular hypertrophy, asymmetric septal hypertro· 
phy or globally decreased left ventricular function was 
Friedreich's ataxia, a progressive heredofamilial disorder 
with an autosomal recessive mode of transmission, is char-
acterized by degeneration of the posterior columns and of 
the corticospinal and posterior spinocerebellar tracts (1,2). 
Symptoms usually begin at or before puberty, with a mean 
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identified in one patient in each category, although the 
study was not designed for longitudinal follow·up. Two 
patients died, and necropsy revealed in both a minimally 
dilated but flabby left ventricle. 
On the basis of electrocardiographic and vectorcar· 
diographic and echocardiographic data, 95% of patients 
had one or more disorders. The most common abnor· 
mality was segmental myocardial "dystrophy" (electro· 
cardiographic QRS initial force abnormalities), but global 
left ventricular hypokinesia occurred more often than 
previously recognized. Concentric and asymmetric hy· 
pertrophic cardiomyopathy were equally prevalent but 
their overall incidence was less than that previously reo 
ported. It is not known why a phenotypically homoge· 
neous neuropathic disease is accompanied by disparate 
types of cardiac involvement and why a nonmyopathic 
systemic disorder afflicts the myocardium. 
(J Am Coli CardioI1986;7:1370-8) 
age of onset of 9 years (range 2 to 25) (1-5). Early reports 
(6) contended that death came two to three decades after 
onset, but some patients have a normal life span. 
Just where this spinocerebellar degenerative disorder fits 
into the complex framework of hereditary ataxias is unre-
solved. Phenotypically similar disorders (Charcot-Marie-
Tooth syndrome, the cerebellar ataxias, familial spastic 
paralysis, Roussy-Levy syndrome) are seldom if ever as-
sociated with heart disease (5). When strict neurologic and 
genetic criteria were used to identify a homogeneous group 
of patients with Friedreich's ataxia (2,5,6), cardiac involve-
ment was found in more than 90% of subjects, and with 
longitudinal follow-up the incidence was 100% (7). Pro-
gressively severe ataxia occurs long before clinically overt 
heart disease, although occasionally the reverse is true (8). 
There is no relation between the degrees of neurologic and 
cardiac involvement (9). 
Heart disease is often the cause of death (1-6). Because 
the neuromuscular disorder curtails physical activity, car-
diac symptoms may await the advent of advanced involve-
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ment of the myocardium, Severe scoliosis and neuromu~­
cular impairment of respiratory muscles result in abnormal 
lung function and noncardiac dyspnea, Electrocardiography, 
vectorcardiography and echocardiography materially assist 
in identifying the presence, type and severity of the heart 
disease, Conversely, the chest X-ray film is often misleading 
because of distortion of the bony thorax, 
There is reason to believe that phenotypically identical 
Friedreich's patients are not biochemically homogeneous 
(10-14), Accordingly, the cardiac expressions might be ex-
pected to vary, To establish the prevalence and to charac-
terize the types of involvement of the heart in phenotypically 
identical subjects, 75 consecutive patients with classic Frie-
dreich's ataxia were prospectively studied utilizing electro-
cardiography, vectorcardiography and M-mode and two-
dimensional echocardiography. 
Methods 
Study patients. All patients were drawn from the Ataxia 
Clinic, Reed Neurological Institute, University of Califor-
nia, Los Angeles between January 1978 and December 1984. 
The protocol was approved by the University Human Sub-
jects Protection Committee. 
The study comprised 39 male and 36 female patients, 
aged 10 to 66 years (mean 24), who satisfied the strict 
clinical neurologic and laboratory diagnostic criteria of 
Harding (6) and of Kark and Rodriguez-Budelli (10). Pa-
tients also fit the differing sets of criteria for the inbred 
population of Quebec (1,3). In all cases, acquired or in-
herited diseases that mimic Friedreich's ataxia were ex-
cluded (10). The time that elapsed from diagnosis (onset of 
symptoms) to time of entry into this study averaged 14 ± 
11 years (SO) with a range from 0 to 62 years. The oldest 
patient, aged 66 years, had a diagnosis of typical hereditary 
Friedreich's ataxia at age 4. Data were derived from elec-
trocardiograms in all 75 patients, vectorcardiograms in 34 
and M-mode and two-dimensional echocardiograms in 58. 
Although the study was not designed for longitudinal follow-
up, a number of patients were studied more than once during 
the observation period. 
Electrocardiography and vectorcardiography. Twelve 
lead scalar electrocardiograms were recorded at rest with 
the subject as close to supine as the thoracic bony distortion 
permitted. Vectorcardiograms utilized the Frank system, a 
Hewlett-Packard 1520-A model recorder and orthogonal scalar 
leads X, Y and Z. Interpretations of electrocardiograms and 
vectorcardiograms were in accordance with accepted norms 
for all age groups (15). 
Echocardiography. Using commercially available 
equipment, standard two-dimensional echocardiographic 
parasternal and apical views were recorded on III inch (1.27 
cm) videotape allowing frame by frame, real-time and fast 
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review analysis. M-mode echocardiograms were displayed 
on standard strip-chart recorders. Echocardiograms of the 
ventricular septum and left ventricular posterior wall were 
imaged just below the tips of the mitral leaflets. Two ob-
servers (unaware of patient identity or electrocardiographic 
and vectorcardiographic data) independently used calipers 
for measurements to the closest millimeter according to the 
American Society of Echocardiography recommendations 
(leading edge methodology) (16). From these measure-
ments, fractional shortening of the left ventricular minor 
dimension was derived from [(end-diastolic dimension -
end-systolic dimension)/end-diastolic dimension] x 100. 
Normal values for fractional shortening in our laboratory 
are 27 to 49%. 
The two-dimensional echocardiograms were also ana-
lyzed for ventricular chamber size and left ventricular wall 
thickness and motion. Concentric hypertrophy and asym-
metric septal hypertrophy were meticulously sought. Wall 
motion was qualitatively assessed as normal, hypokinetic, 
akinetic or dyskinetic. Two observers unaware of other pa-
tient data had to agree before conclusions were considered 
valid. The two-dimensional echocardiogram established 
whether or not wall motion was uniform and provided as-
surance that M-mode assessments of left ventricular per-
formance were representative of the entire ventricle. 
Mitral mlve motion was studied by M-mode and two-
dimensional echocardiography for superior systolic dis-
placement of the bellies of the leaflets and of the coaptation 
point relative to the plane of the mitral anulus (17,18) and 
for systolic anterior motion of the anterior mitral leaflet. 
The following echocardiographic classification of superior 
systolic mitral valve displacement was used ( 17,18): 1) mild: 
coaptation point on the ventricular side of the mitral anular 
plane with either or both leaflet bellies barely on the atrial 
side; 2) moderate: coaptation point at the plane of the anulus, 
and either or both leaflet bellies clearly but moderately on 
the atrial side; and 3) severe: coaptation point and both 
leaflet bellies conspicuously on the atrial side of the anular 
plane. Physiologic maneuvers were not possible because of 
patient disability, and pharmacologic interventions were 
proscribed by the Human Subjects Protection Committee. 
Concentric left ventricular hypertrophy was diagnosed 
when ventricular septal and left ventricular free wall dia-
stolic thicknesses exceeded published norms for age and 
body size (19). Asymmetric septal hypertrophy was diag-
nosed when the ventricular septum was thickened and ex-
ceeded posterior left ventricular free wall thickness (behind 
the mitral valve) by a septum/posterior wall ratio of greater 
than 1.3 on the M-mode recording. The two-dimensional 
echocardiogram allowed examination of the septum from 
apex to base and of the anterior and posterior septum for 
variations in asymmetric septal hypertrophy. 
Statistics. Data are expressed as mean values ± 1 SO. 
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Results 
Electrocardiography and vectorcardiography. Inap-
propriate sinus tachycardia occurred in 5 (6%) of the 75 
patients, less commonly than previously reported (4,8,20--22), 
Ventricular premature complexes were infrequent, uniform 
and single, A short PR interval without delta waves (:=; 0,12 
second) was present in 18 (24%), The QRS axis was normal 
in 44 (59%), but showed right axis deviation that was oc-
casionally markedly superior and rightward (Fig, 1 and 2) 
in 30 (40%); left axis deviation was seen in only 1 subject. 
Criteria for left ventricular hypertrophy were satisfied in 12 
patients (16%). Abnormally broad inferolateral Q waves in 
10 (13%), and broad, tall right precordial R waves in 15 
(20%) were about evenly distributed (Fig, 2), Nonspecific 
ST -T wave changes were the most common abnormality 
(59 patients [75%]). Entirely normal electrocardiograms were 
recorded in only six patients (8%), 
Vectorcardiograms in 15 (44%) of the 34 patients re-
vealed abnormal anterior initial forces that coincided with 
the prominent R waves in lead V I, Only one tracing had 
vectorcardiographic evidence of right ventricular hypertro-
phy. Except for one patient with biventricular hypertrophy 
(see later), neither right ventricular enlargement nor hyper-
trophy was evident on echocardiography, Six of the 12 
patients with electrocardiographic left ventricular hypertro-
phy had vectorcardiograms; 2 of the 6 had vectorcardio-
graphic evidence of left ventricular hypertrophy but no left 
ventricular hypertrophy on echocardiography. Conversely, 
vectorcardiograms failed to meet criteria for hypertrophy in 
two subjects with echocardiographic left ventricular hyper-
trophy, The vectorcardiogram often displayed QRS vector 
loops that were irregular and notched during the course of 
inscription (23), 
Echocardiography. Echocardiographic results in 57 
(77%) of the 75 patients are shown in Figure 3. Fifty-eight 
patients had M-mode echocardiograms; one study was tech-
nically unsatisfactory, Of the 57 subjects with acceptable 
Figure 1. Electrocardiographic/vectorcardiographic results in 75 
patients. ABN Q = abnormal Q waves; L VH = left ventricular 
hypertrophy; NORM. = normal; ! PR = short PR interval; 
RAD = right axis deviation; i RV 1 = increased R wave in lead 
V,; ST-T = abnormalities of ST segments and T waves. 
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VI V:z ~ " ~ '4s Figure 2. Electrocardiogram in a 28 year old man. The QRS axis 
shows marked right axis deviation. There are 40 ms Q waves in 
leads 2, 3 and aVF. A prominent 60 ms R wave appears in lead 
V,. The vectorcardiogram and echocardiogram showed no evi-
dence of ventricular hypertrophy, The electrocardiographic pattern 
reflects loss of inferior and posterior electrical forces without a 
corresponding regional wall motion abnormality on echo-
cardiography. 
M-mode tracings, 47 also had two-dimensional echocardio-
grams, Seventeen patients (23%) declined echocardio-
graphic study, 
Concentric left ventricular hypertrophy was present in 6 
(11 %) of 57 echocardiograms. Diastolic mean septal thick-
ness in the six patients averaged 13.4 ± 1.8 mm and pos-
terior wall thickness averaged 12.2 ± 0.8 mm, None of 
the six had systemic hypertension. Two-dimensional echo-
cardiograms were available in five of these six patients and 
Figure 3. Echocardiographic results in 57 patients. ASH = asym-
metric septal hypertrophy; CL VH = concentric left ventricular 
hypertrophy; DCM = "dilated" cardiomyopathy; MVP = mitral 
valve prolapse; SAM = systolic anterior motion of the anterior 
mitral leaflet. 
100r-----------------------, 
80 
% 60 
PATIENTS 
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40 
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* ** 
*Of 5 ASH: 2 SAM 
** Of 4 SAM: 2 ASH, 2 MVP 
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confirmed concentric left ventricular hypertrophy. One pa-
tient had biventricular hypertrophy on two-dimensional im-
aging. In this isolated patient with echographic evidence of 
right ventricular hypertrophy, there was an increased R wave 
in lead VI. All other broad, tall R waves in lead VI were 
unassociated with echographic evidence of right ventricular 
hypertrophy and were not specifically related to the presence 
of asymmetric septal hypertrophy. No patient exhibited iso-
lated echocardiographic right ventricular cavity enlargement 
or increased free wall thickness. One patient with normal 
wall thicknesses at age 13 years developed concentric left 
ventricular hypertrophy by age 16 (Fig. 4). 
Asymmetric septal hypertrophy (Fig. 5) was present in 5 
(9%) of the 57 echocardiograms. It was evident on both M-
mode tracings and two-dimensional recordings in four pa-
tients; the fifth patient had mid septal asymmetric hypertro-
phy missed by M-mode recording. In the four patients with 
.. 
• 
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Figure 4. Two-dimensional paraster-
nal long- and short-axis views of an 
echocardiogram in a 16 year old boy 
with concentric left ventricular hyper-
trophy. At age 13 years, his echocar-
diogram was normal. Ao = aorta; 
LA = left atrium; LV = left ventricle; 
pw = posterior wall; vs = ventricular 
septum. 
asymmetric septal hypertrophy by M-mode recording, the 
study revealed a mean septal/posterior wall ratio of 2.1 ± 
0.7 and mean septal thickness of 18.0 ± 3.3 mm. Systolic 
anterior mitral valve motion was present in two of the five 
patients with asymmetric septal hypertrophy. It was also 
identified in two patients with neither asymmetric septal 
hypertrophy nor concentric left ventricular hypertrophy and 
was attributed to "chordal laxity ." In one patient an initially 
normal echocardiogram altered over 3 years to one showing 
asymmetric septal hypertrophy (septum = 14 mm, posterior 
wall = 10 mm). 
Globally decreased left ventricular function was identi-
fied in four patients (7%) who had a mean value for frac-
tional shortening of 21 ± 5% (range 15 to 26%). In each 
of the other 53 patients fractional shortening was greater 
than 27%. No patient exhibited regional wail motion ab-
normalities on real time imaging. Mean left ventricular di-
Figure S. Two-dimensional paraster-
nal long- and short-axis views of an 
echocardiogram in a patient with 
asymmetric septal hypertrophy (ar-
rows). Real time imaging identified 
systolic anterior movement of the an-
terior mitral leaflet. Abbreviations as 
in Figure 4. 
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Figure 6. Gross and histologic speci-
mens from a 17 year old boy whose 
echocardiogram progressed from nor-
mal at age 13 years to a minimally di-
lated hypocontractile left ventricle 3 to 
4 years later. The gross specimen (left) 
shows the mildly dilated left ventricle 
(LV) with normal wall thickness; the 
walls were flabby. The microscopic sec-
tion (right) from the left ventricular free 
wall shows marked connective tissue re-
placement. Small vessel coronary artery 
disease was not identified, although it 
was specifically sought. Ao = aorta. 
astolic dimension in the four patients with global depression 
of function was 50 ± 4 mm (range 47 to 54), a value that 
was at the upper limits of normal for body size, sex and 
age. The 32 year old woman with a left ventricular diastolic 
dimension of 47 mm and a fractional shortening of 15% 
died suddenly. Necropsy identified a minimally dilated but 
flabby left ventricular myocardium with increased connec-
tive tissue; the electrocardiogram revealed low QRS voltage. 
A 17 year old boy died after progression from normal echo-
cardiographic findings at age 13 years (left ventricular di-
astolic dimension 24 mm, fractional shortening 33%) to a 
minimally dilated but hypo functional left ventricle (left ven-
tricular diastolic dimension 53 mm, fractional shortening 
25%) 4 years later (Fig. 6); the QRS voltage in this patient 
was normal except for an increased R wave in lead V I. The 
electrocardiogram in one of the other two patients with 
global hypokinesia revealed generalized low voltage QRS 
complexes. 
Mild to moderate superior systolic displacement of one 
or both mitral leaflets was seen on two-dimensional echo-
cardiograms in 8 (14%) of the 57 patients. Five additional 
patients with only M-mode tracings had mild holosystolic 
or mid to late systolic sagging. The mild to moderate degree 
of superior systolic displacement was believed to be within 
the Gaussian distribution of normal (17,18) (see later). On 
careful auscultation, no patient had signs of pathologic mi-
tral valve prolapse. 
Combined electrocardiographic and echocardio-
graphic results (Fig. 7). Only 3 (5%) of 57 recordings 
were identified as completely normal. Twenty-six (46%) 
patients had normal M-mode tracings; 18 (38%) with both 
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M-mode and two-dimensional echocardiograms had no rec-
ognizable abnormality. Among the II patients with either 
echocardiographic asymmetric septal or concentric left ven-
tricular hypertrophy, none of the former had left ventricular 
hypertrophy by electrocardiogram, whereas 5 of 6 patients 
with concentric left ventricular hypertrophy on echocardi-
ography had electrocardiographic hypertrophy. Conversely, 
of the 11 patients with electrocardiographic left ventricular 
hypertrophy who had echocardiograms, 6 had normal wall 
thickness on echocardiography. All patients with hypertro-
phy on echocardiography, however, had ST -T wave ab-
normalities on electrocardiography. 
Except in one patient with biventricular hypertrophy on 
echocardiography, an increase in the R wave in lead V I did 
Figure 7. Electrocardiographic (ECG) versus echocardiographic 
(ECHO) left ventricular hypertrophy (LVH). Other abbreviations 
as in Figure 3. 
*ECG + LVH 
ECHO-LV 
35% 
29%, 
(5/171 
* OF 12 ECG + LVH, II HAD AN ECHO. 
** NONE WITH ECHO+ASH HAD ECG+LVH 
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not coincide with right ventricular enlargement or hyper-
trophy by echocardiography, Routine pulmonary function 
testing was not performed. We therefore cannot comment 
on whether an R wave increase in lead V J was associated 
with abnormal spirometric findings or lung volumes. Initial 
force abnormalities, either Q waves or R waves, are not 
explained by abnormal thoracic configuration (24). 
Discussion 
Involvement of the heart, usually occult and asympto-
matic, is virtually universal in Friedreich' s ataxia and is 
readily detected (92%) by standard scalar electrocardiog-
raphy (Fig, I) (7,22,25,26). On serial electrocardiography, 
abnormalities may be delayed for as long as two decades 
after onset of the neurologic disease (25). If the observed 
superior systolic motion of the mitral valve is truly within 
the range of normal (17), then an abnormal echocardiogram 
was seen in only 27%. However, the combination of electro-
cardiography and echocardiography detected one or more 
abnormalities in 95% of our patients. There was no corre-
lation between the type of heart involvement and the age 
of the patient or duration of neurologic symptoms. 
Incidence of left ventricular hypertrophy. Hyper-
trophic cardiomyopathy was less frequent (II [20%1 of 57) 
in our patients than in the patients in previous reports (26-38), 
and in our patients, concentric (Fig. 4) and asymmetric (Fig. 
5) hypertrophy were equally prevalent. The two varieties 
of hypertrophy probably represent parts of a continuum (39). 
The lower incidence of left ventricular hypertrophy is un-
doubtedly a function of the time of study in the natural 
history of each patient, but it is likely that our data represent 
a relatively accurate overall prevalence based on a pro-
spective sequential study of all patients with Friedreich' s 
ataxia, rather than a selective study of those suspected of 
having cardiac involvement. Electrocardiographic left ven-
tricular hypertrophy in Friedreich' s ataxia is not always 
present with echocardiographic hypertrophic cardio-
myopathy, although T wave abnormalities occur consist-
ently (25,28). A left ventricular outflow gradient has been 
reported in some cases with disproportionate septal thick-
ness (27-31,34,35), but not in others (32,36,38). However, 
septal cellular disarray, the histologic hallmark of genetic 
hypertrophic cardiomyopathy, has not been established at 
necropsy in Friedreich's ataxia (5,20,40-44), This obser-
vation may shed light on why the potentially malignant 
ventricular arrhythmias that prevail in genetic hypertrophic 
cardiomyopathy are essentially unknown in Friedreich's 
ataxia. Conduction velocity and stability of impulse prop-
agation in cardiac muscle not only are dependent on the 
membrane ionic properties but also are highly dependent on 
cell geometry and the specific arrangements of the cellular 
connections (45). Cellular disarray is theoretically inher-
ently electrically unstable, and may be the fundamental cause 
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of ventricular electrical instability in genetic hypertrophic 
cardiomyopathy. By contrast, Friedreich's ataxia is not 
characterized by either cellular disarray or ventricular ar-
rhythmias. 
Nonhypertrophic cardiomyopathy. A globally hypo-
functional left ventricle, generally not dilated, has been 
infrequently reported in Friedreich's ataxia (25,26,32,37) 
and was identified in 7% of patients in our study, Global 
depression of left ventricular function with little or no en-
largement by absolute measurements does not correspond 
to "dilated cardiomyopathy" as commonly defined 
(26,46,47). Left ventricular dimensions were at the upper 
limits of normal for age, sex and body size in each of our 
patients. Grenadier et al. (37) observed left ventricular hy-
pokinesia on echocardiography in 40% of selected cases of 
Friedreich's ataxia. However, our subjects were studied solely 
on the basis of the diagnosis of the neuropathic disease, not 
because of suspected cardiac involvement. The 23% of our 
population (17 of 75 patients) who declined echocardiog-
raphy were clinically the same as the other 77%. 
We are not persuaded that global left ventricular hypok-
inesia ("minimally dilated cardiomyopathy") is the end-
stage of hypertrophic cardiomyopathy (38), but instead 
believe it to be a fundamentally different type of cardiac 
involvement, which we call "dystrophic." This view is 
supported by the flabby myocardium with normal wall thick-
ness found in two of our necropsy patients who exhibited 
premortem progression on echocardiography from a normal 
to a minimally dilated but globally hypofunctionalleft ven-
tricle with normal wall thickness (Fig. 6). By contrast, two 
other patients progressed from a normal to a hypertrophic 
left ventricle (concentric in one, asymmetric septal hyper-
trophy in another). None of our 10 patients with cardiac 
hypertrophy (concentric or asymmetric) on echocardiog-
raphy exhibited ventricular dilation or decreased left ven-
tricular function. Furthermore, two of our four patients with 
globally depressed left ventricular function exhibited a gen-
eralized decrease in QRS voltage, in contrast to normal or 
increased voltage in the hypertrophic group. Our observa-
tions imply that "minimally dilated cardiomyopathy" rep-
resents an uncommon late stage of the prevalent regional 
myocardial involvement believed to be reflected in the initial 
force abnormalities of electrocardiograms and vectorcardi-
ograms. It remains unclear why the regional electrocardio-
graphic alterations are not associated with echographic wall 
motion abnormalities. 
Intimal proliferation in small intramural coronary ar-
teries has been reported in Friedreich's ataxia (40,48), but 
no relation was established between this small vessel coro-
nary arteriopathy and either regional or global myocardial 
dystrophy (43). In Duchenne' s muscular dystrophy, a neg-
ative correlation was also found between an analogous small 
vessel coronary arteriopathy and dystrophic involvement of 
the myocardium (49). Whether there is a connection be-
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tween diabetes mellitus in Friedreich's ataxia (50,51) and 
either the small vessel coronary artery disease or nonco-
ronary interstitial disease of diabetes is speculative. In any 
event, the incidence of regional electrocardiographic myo-
cardial involvement far exceeds the incidence of clinical 
diabetes. 
There appear to be two fundamentally different types of 
cardiac disease in Friedreich's ataxia: 1) a common" dys-
trophic" form manifested by electrocardiographic initial force 
deformities without detectable echo graphic wall motion ab-
normalities (Fig. 3), but occasionally by extension through-
out the left ventricle with global hypokinesia and reduced 
QRS voltage; and 2) a hypertrophic form represented by 
symmetric (Fig. 4) or asymmetric (Fig. 5) left ventricular 
hypertrophy with normal cavity size and ventricular function. 
Metabolic abnormalities. It is not known why a non-
myopathic spinocerebellar-corticospinal disorder is accom-
panied by two widely disparate types of cardiac involvement 
(myocardial "dystrophy" and myocardial hypertrophy). An 
important implication is that the genetic marker, ultimately 
biochemical, differs in phenotypically identical patients 
(39,50-53). There is precedent for genetically determined 
regional myocardial dystrophy and regional abnormalities 
of myocardial metabolism in certain forms of neuromuscular 
disease (49). 
A number of biochemical abnormalities have been found 
in families with Friedreich's ataxia. Defects of pyruvate 
metabolism include abnormal glucose-pyruvate tests (54,55), 
abnormal pyruvate infusion tests (56), abnormalities of the 
oxidation of pyruvate by biopsied or cultured tissues (10,57) 
and abnormalities of the activity of the pyruvate dehydro-
genase complex (13,58-60), of its third catalytic component 
(lipoamide dehydrogenase) (61), of two distinct "malic en-
zymes" (11,57) and possibly of pyruvate carboxylase (12,62). 
Hereditable defects of deoxyribonucleic acid repair have 
been reported (63). No one defect is found in every family. 
Each enzyme abnormality conceivably reflects a distinct 
underlying genetic lesion, but studies thus far are limited 
to enzymes of the pyruvate dehydrogenase complex (13). 
Fibroblasts from patients with Friedreich's ataxia were found 
deficient in mitochondrial malic enzyme, whose activity is 
normally highest in the heart and nervous system (57). The 
precise role of this enzyme is poorly defined, but skeletal 
muscle and myocardial mitochondrial malic enzyme may 
playa role in amino acid catabolism (64). 
Catecholamine hypothesis. The relation between a 
nonmyopathic spinocerebellar-corticospinal disorder and an 
increase in ventricular mass is also an enigma. A unifying 
thread may be abnormal catecholamine metabolism. In-
creased sympathetic stimulation has been held responsible 
for inappropriate sinus tachycardia in Friedreich's ataxia 
(5,65,66) since the observations of Loiseau in 1938 (67). 
The "catecholamine hypothesis" is a focus oflively interest 
in the pathogenesis of genetic hypertrophic cardiomyopathy 
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(39,44,66). Norepinephrine acts as a hormone that stimu-
lates myocyte growth (hypertrophy) even in tissue culture 
(68). Importantly, increased plasma catecholamines have 
been reported in patients with Friedreich's ataxia (69,70). 
Superior systolic mitral valve motion. Echocardio-
graphic evidence of what might be interpreted as "mitral 
valve prolapse" deserves comment. None of our patients 
in whom superior systolic displacement of one or more 
mitral leaflets was identified on echocardiography had either 
mid to late systolic clicks or a late systolic murmur. Reliable 
imaging of mitral valve systolic motion on M-mode echo-
cardiography can be problematic in the face of the marked 
thoracic deformity in patients with Friedreich' s ataxia (71). 
More important, none of the two-dimensional echocardio-
grams identified more than mild to moderate superior sys-
tolic motion of the mitral leaflets, a degree probably within 
the Gaussian distribution of normal (17,18,72). 
Conclusions 
Involvement of the heart is common in Friedreich's ataxia; 
it is usually asymptomatic and is readily detected by electro-
cardiography and echocardiography. Phenotypically iden-
tical patients have two widely disparate types of cardiac 
disease, dystrophic and hypertrophic, implying a basic ge-
netic (biochemical) difference in what is otherwise regarded 
as a clinically homogeneous patient group. "Dystrophic" 
involvement of the heart is usually segmental, but extension 
to global hypofunction is more frequent than previously 
recognized. Hypertrophic cardiomyopathy is less common 
than previously reported, is equally prevalent as concentric 
or asymmetric hypertrophy and may develop relatively rapidly 
Two fundamental questions persist: 1) Why does a non-
myopathic spinocerebellar-posterior column-corticospinal 
disorder afflict the myocardium?; and 2) Why does a phe-
notypically homogeneous neuropathic disorder express itself 
as two basically different types of cardiac disease? 
References 
I. Andermann E, Remillard GM, Goyer C, Blitzer L, Anderman F, 
Barbeau A. Genetic and family studies in Friedreich's ataxia. J Can 
Sci Neurol 1976;3:287-301. 
2. Geoffroy G, Barbeau A, Breton G, et a\. Clinical description and 
roentgenologic evaluation of patients with Friedreich' s ataxia. J Can 
Sci Neurol 1976;3:279-86. 
3. Barbeau A. Quebec cooperative study of Friedreich's ataxia. Phase I: 
A prospective survey of 50 cases. J Can Sci Neurol 1976;3:269-86. 
4. Rosenberg RN. Biochemical genetics of neurological disease. N Engl 
J Med 1981;305:1181-93. 
5. Thoren C. Cardiomyopathy in Friedreich's ataxia. Acta Paediatr, 
Uppsala 1964;53 (suppl 153):1-36. 
6. Hardmg AE. Friedrelch's ataxia: a clInical and genetic study of 90 
families With an analysis of early diagnostic criteria and intrafamilial 
clustering of clinical features. Brain 1981;\04:589-620. 
JACC Vol 7, No 6 
June 1986 1370-8 
7. Thoren C. CardIOmyopathy In Friedreich\ ataxia (follow-up study of 
ECG and effects of beta-receptor blockade) (abstr). Eur 1 Cardiol 
1977;5:282. 
8. Thilenius OG, Grossman Bl Fnedreich's ataxia wtth heart disease In 
children. Pediatncs 1961;27:246-54. 
9. Cote M, Davignon A, Elias G, et al. Hemodynamic findIngs In Fried-
reich's ataxia. J Can Sci Neurol 1976;3:333-6. 
10. Kark RAP, Rodriguez-Budelli MM. ClImcal correlatlons of partial 
deficiency of lipoamide dehydrogenase. Neurology 1979;29: 1006-13. 
II. Bottachi E, Di Donato S. Skeletal muscle NAD + (P) and NADP+-
dependent malic enzyme and Fnedreich ataxia. Neurology 
1983;33:712-6. 
12. Dykstra UJ, Willems JL, 100sten EMG, Gabreels FIM Friedrelch 
ataxia and low pyruvate carboxylase activtty In liver and fibroblasts 
Ann Neurol 1983;13.325-7. 
13. Kark RAP, Rodriguez-Budelli M. Pyruvate dehydrogenase deficiency 
In spinocerebellar degenerations. Neurology 1979;29: 126-31 
14. Stumpf DA, Parks lK, Parker WD. Fnedreich's disease IV. Reduced 
mitochondrial malic enzyme activity In heterozygotes. Neurology 
1983,33:780-3. 
15. Cooksey 10, Dunn M, Massie E. ClInical Vectorcardiography and 
Electrocardiography. 2nd ed. Chicago: Year Book Medical PublIsher" 
1976:145-71. 
16. Sahn Dl, DeMaria A, Klsslo 1, Weyman A. RecommendatIOns re-
garding quantitation in M-mode echocardiography. results of a survey 
of echocardiographlc measurements. Circulation 1978,58' 1072-83 
17. Warth DC, KIng ME, Cohen 1M, Resoriero VL, Marcus E, Weyman 
AE. Prevalence of mitral valve prolapse in a nonnal pediatnc popu-
lation. 1 Am Coli Cardiol 1985;5: 1173-7. 
18. Perl off lK, ChIld IS, Edward lE. New gUIdelines for the climcal 
diagnOSIs of mitral valve prolapse Am 1 Cardiol (in press). 
19. Hagan AD, Di Sessa TG, Bloor CM, Calleja HB. Two-dimenSIOnal 
Echocardiography. Boston. Little, Brown, 1983:551-5 
20. Ivemark B, Thoren C. Pathology of the heart In Fnedreich's ataxia. 
Acta Med Scand 1964;175:227-37. 
21. Boyer SH, Chisholm AW, McKuslck VA. CardiaC aspects of Fned-
reich's ataxia. Circulation 1962;25:493-505. 
22. Malo S, Latom Y, Cote M, Geoffroy G, Lemieux B, Barbeau A 
Electrocardiographic and vectorcardIOgraphic findIngs In Friedreich's 
ataxia. 1 Can Sci Neurol 1967;3:323-8. 
23. Gregonni L, Valentim R, Libretti A The vectorcardiogram In Fned-
reich's ataxia Am Heart 1 1974;87:158-63. 
24. De Leon AC, Perloff JK, Twigg H, Majd M. The straight back syn-
drome ClInical cardIOvascular manifestations. Circulation 1965; 
32:193-203. 
25. Harding AE, Hewer RL. The heart disease of Friedreich's ataxia: a 
clinical and electrocardiographic study of 115 patients, With an analysis 
of serial electrocardIOgraphic changes in 30 cases. Quant 1 Med 
1983;28:489-502 
26. Pentland B, Fox KAA. The heart in Friedreich's ataxia J Neurol 
Neurosurg Psychiatry 1983;46: 1138-42. 
27. Ruschhaupt DG, ThIlmius OG, Cassels DE Fnedrelch's ataxia as-
sociated with idiopathic hypertrophic subaortic stenosis. Am Heart 1 
1976;84:95-102. 
28. Smith ER, Sangalang VE, Heffernan LP, Welch JP, Flemington CS 
Hypertrophic cardiomyopathy: the heart disease of Friedreich's ataxia. 
Am Heart 1 1977;94:428-34. 
29. Soulie P, Vernant P, Gadeau S. Le coeur dans la maladie de Friedreich. 
Etudie hemodynamic droite et gauche. Mal Cardiov 1966;7:369-86. 
30. Gach JV, Andriange M, Franck G. Hypertrophic obstructive cardIO-
myopathy and Fnedreich's ataxia. Report of a case and review of 
literature. Am J Cardio1 1971;27:436-41. 
31. Boehm TM, Dickerson RB, Glasser SP. Hypertrophic subaortlc ste-
CHILD ET AL 
CARDIAC DISEASE IN FRIEDREICH'S ATAXIA 
1377 
nosls occurrIng m a pallent wtth fnedrelch's ataxia. Am J Med SCI 
1970:260.279-84. 
32 Guenn R, ElIas G, Davignon A, et a!. Cardiac anglOgraphlc findmgs 
m Fnedrelch's ataxia. J Can SCI Neurol 1976,3.337-42 
33 Gattiker HF, DaVignon A, BozlO A, et al EchocardlOgraphic findings 
m Fnedrelch's ataxia. 1 Can SCI Neurol 1976,3'329-32 
34 Weiss E, Kronzon I, Wmlr HE, Berger AR. Case report echocar-
dlOgraphlC observalions m pallents wllh Fnedrelch' s ataxia Am 1 
Med Sci 1981,282: 136-40. 
35. Pa,ternac A, Drol R, Petltclerc R, Harvey C, Andennann E, Barbeau 
A Hypertrophic cardIOmyopathy m fnedrelch's ataxia' symmetnc or 
asymmetnc'll Can Sci Neurol 1980,7:379-82 
36 SI. 10hn Sutton MG, Olukotun AY, TaJlk AJ, Lovett 11, GlUlIam ER. 
Left ventncular function m Fnedreich'; ataxia. An echocardiographlc 
,tudy. Br Heart J 1980:44:309-16. 
37 Grenadier E, Goldberg Sl, Stern LZ, Feldman L. M-mode and two-
dimensIOnal echocardiographlc exammation of patients With Fried-
reich's ataxia. 1 CardlOvasc Ultrasonog 1984:3:5-12. 
38 Gottdiener IS, Hawley RJ, Maron BJ, Bertonni TF, Engle WK Char-
actensllcs of the cardiac hypertrophy in Friedreich's ataxia. Am Heart 
1 1982;103:525-31. 
39. Barbeau A PathophYSiology of Fnedrelch's ataxia. In: Matthews WB, 
Glaser GH, eds Recent Advances in ClImcal Neurology. No 3. Edin-
burgh: Churchill liVIngstone, 1982; 129. 
40. Graham GR. Fnedrelch\ disease In: CardIOmyopathies Ciba Foun-
dallon Symposium Boston. Little, Brown, 1964:358. 
41. Hewer RL. The heart m Fnedrelch', ataXia. Br Heart 1 1969,31 :5-14. 
42 Hartman 1M, Booth RW Fnedreich\ ataXIa A neurocardiac disease. 
Am Heart 1 1960,60:716-20 
43. Sanchez-Casls G, Cote M, Barbeau A. Pathology of the heart in 
Fnedreich'; ataxia: review of the lIterature and report of one case. 1 
Can SCI Neurol 1976,3:349-54. 
44 Perl off lK PathogeneSIs of hypertrophIC cardIOmyopathy. In. Good-
WIO IF, ed. Heart Muscle Disease. Lancaster: MTP Press, 1985:7-22 
45 Spach NS, Kootsey 1M. The nature of electncal propagatIOn In cardiac 
muscle. Am 1 Physiol 1983:244:H3-22. 
46. Perloff JK. CardIOmyopathies 10 mfants and children. In: Moss Al, 
ed. Pediatncs Update New York: ElseVier, 1985'187-204. 
47. Keren A, BillIngham ME, Wemtraub D, Stmson EB, Popp RL. Mildly 
dIlated congestive cardiomyopathy Circulalion 1985;72.302-9. 
48. lame, TN, Fisch C. Observation, on the cardiovascular IOvolvement 
In Fnedrelch's ataxia. Am Heart J 1963;66 164-75 
49. Perl off JK, Henze E, Schelbert HR. Alteration, 10 regIOnal myocardial 
metabolIsm, perfUSion and wall motIOn In Duchenne muscular dys-
trophy studied by radlOnuciide ImaglOg CirculatIOn 1984:69:33-42 
50 Rosenberg RN GenetIC vanatlOn and neurologICal disease. Trends 
NeurosCi 1980:3: 144-8. 
51 Kark RAP, Becker DM. Mulllple genotypes, muillple phenotypes and 
partial defect, Muscle Nerve 1981:4:31-40 
52 10hnson WG. The clImcal spectrum of hexosaminidase defiCiency 
diseases. Neurology 1981 :31: 1453-6. 
53. Rowland LP. Molecular genetics, pseudogenetics and clImcal neu-
rology. The Robert Wartenberg Lecture. Neurology 1983:33.179-95. 
54. Kark RAP, Blass JP, Engle WK. Pyruvate oxidation in neuromuscular 
diseases. EVidence of a genellc defect III two families with the clinical 
syndrome of Friedreich's ataxia Neurology 1974;24:964-71. 
55 Barbeau A, Melancon S, Butterworth RF, Filla A, Izumi K, Ngo TT. 
Pyruvate dehydrogenase complex In Friedrelch's ataxia. Adv Neurol 
1978;21:203-17 
56 Dykstra U, Gabreels F, 100sten E, et al Friedreich's ataxia: intra-
venous pyruvate load to demonstrate a defect In pyruvate metabolIsm 
Neurology 1984:34: 1493-7. 
1378 CHILD ET AL. 
CARDIAC DISEASE IN FRIEDREICH'S ATAXIA 
57 Stumpf DA, Parb JD, Eguren LA, Haas RH FnedreICh's ataxIa. IlL 
Mltochondnal malIc enzyme deficIency Neurology 1982;32:221-7 
58. Blass JP, Kark RAP, Menon NK Low actIvltIe, of the pyruvate and 
oxoglutarate dehydrogena,e complexes In five patIents WIth Fne-
drelch', ataxIa, N Engl J Med 1976;295:62-7. 
59. Shapcott 0, Melancon S, Butterworth RF, et al. Glucose and insulIn 
metaboli,m In Friedrelch's ataxIa J Can SCI Neurol 1976;3:361-4 
60. Bertagnolio B, Uziel G, Bottachi E, Crenna G, D'Angelo A, Di DInato 
S Fnedrelch' s ataxia in Northern Italy II. Biochemical studies In 
cultured cells. Ital J Neurol Sci 1980;1 :239-43. 
61 Kark RAP, Budelli MMR, Becker OM, Weiner LP, Forsythe AB, 
Llpoamide dehydrogenase, rapid heat inactivation in platelets of pa-
tIents WIth recessIvely Inherited ataxia, Neurology 1981 ;31: 199-202 
62. Dykstra UL TiJbels JMF. RUltenbeek W. et al. Pyruvate carboxylase 
is not abnormal in fibroblasts of patients with Fnedreich's ataxIa. Ann 
Neurol 1984;16:262. 
63. Evan~ HL Vijayalaxmi, Pentland B, Newton MS. Mutagen hyper-
sensitIVIty in Friedreich's ataxIa. Ann Hum Genet 1983;47: 193-204, 
64. Lee SH, DaVIS EJ. CarboxylatIOn and decarboxylation reactions: an-
apleurotic flux and removal of cItrate cycle intermediates in skeletal 
muscle. J Bioi Chern 1979;254:420-30. 
JACC Vol 7. No 6 
June 1986 \:170-8 
65. Cote M, Davignon A, Pecko-Drouin K, et al. CardIOlogIcal 'Igm. and 
symptoms In FriedreIch's ataxia. J Can Sci Neurol 1976,3.319-21 
66. GoodWIn JF. Prospec!:' and predIctIon, for the cardiomyopathIes, CIr-
culation 1974:50:210-9. 
67. LOIseau J, Les troubles cardiaques dans la maladle de Fnedreich 
These, Paris 1938 (quoted in Ref. 69) 
68. Simpson p, McGrath A, SavlOn S. Myocyte hypertrophy In neonatal 
rat heart cultures and its regulation by serum and by catecholamines, 
Orc Res 1982:51:787-801. 
69 Pasternac A, Wagniart P, OlivensteIn R, et al. Increased plasma cate-
cholamInes in patients WIth Friedrelch's ataxIa. J Can Sci Neurol 
1982;9: 195-203. 
70 Merkel AD, Barbeau A, Pla,ma catecholamInes in Friedreich's ataxia 
assayed using hIgh performance liqUId chromatography with electro-
chemical detection J Can Sci Neurol 1982;9:205-8. 
71. MarkieWICZ W, London E, Popp RL. Effect of transducer placement 
on echocardiographic mItral valve motion. Am Heart J 1978;96:555-6. 
72. Gavin WA, Pearlman AS, Saal AK, et al. Abnormal mItral leaflet 
coaptation, a nonspecific, two-dimenSIOn echo finding (abstr). Cir-
culation 1983;68(suppl IlI):1lI-365. 
